Renal Cell-expressed TNF Receptor 2, Not Receptor 1, is Essential for the Development of Glomerulonephritis

Overview

Journal J Clin Invest

Specialty General Medicine

Date 2005 Apr 21

PMID 15841213

Citations 57

Authors

Volker Vielhauer

George Stavrakis

Tanya N Mayadas

Affiliations

Soon will be listed here.

Abstract

TNF is essential for the development of glomerulonephritis, an immune-mediated disorder that is a major cause of renal failure worldwide. However, TNF has proinflammatory and immunosuppressive properties that may segregate at the level of the 2 TNF receptors (TNFRs), TNFR1 and TNFR2. TNFR1-deficient mice subjected to immune complex-mediated glomerulonephritis developed less proteinuria and glomerular injury, and fewer renal leukocyte infiltrates at early time points after disease induction, and this was associated with a reduced systemic immune response to nephrotoxic rabbit IgG. However, proteinuria and renal pathology were similar to those in wild-type controls at later time points, when lack of TNFR1 resulted in excessive renal T cell accumulation and an associated reduction in apoptosis of these cells. In sharp contrast, TNFR2-deficient mice were completely protected from glomerulonephritis at all time points, despite an intact systemic immune response. TNFR2 was induced on glomerular endothelial cells of nephritic kidneys, and TNFR2 expression on intrinsic cells, but not leukocytes, was essential for glomerulonephritis and glomerular complement deposition. Thus, TNFR1 promotes systemic immune responses and renal T cell death, while intrinsic cell TNFR2 plays a critical role in complement-dependent tissue injury. Therefore, therapeutic blockade specifically of TNFR2 may be a promising strategy in the treatment of immune-mediated glomerulonephritis.

Citing Articles

Role of baseline soluble tumor necrosis factor receptor 2 as a biomarker in primary podocytopathy: Implications for renal impairment and disease progression.

Nagaram S, Charles P, Nisha Y, Stephen N, Hanumanthappa N, Parameswaran S BMC Nephrol. 2024; 25(1):378.

PMID: 39455940 PMC: 11515380. DOI: 10.1186/s12882-024-03772-y.

Pathogenesis of HIV-associated nephropathy in children and adolescents: taking a hard look 40 years later in the era of gene-environment interactions.

Ray P, Li J, Das J, Xu L, Yu J, Han Z Am J Physiol Renal Physiol. 2024; 327(6):F1049-F1066.

PMID: 39323389 PMC: 11687833. DOI: 10.1152/ajprenal.00208.2024.

Soluble Tumor Necrosis Factor Receptor 2: A Promising Predictive Biomarker for Renal Dysfunction in Membranous Glomerulonephritis.

Nagaram S, Charles P, Nandeesha H, Stephen N, Parameswaran S, Chinnakali P Cureus. 2024; 16(4):e58506.

PMID: 38765394 PMC: 11101981. DOI: 10.7759/cureus.58506.

Apoptotic cell death in disease-Current understanding of the NCCD 2023.

Vitale I, Pietrocola F, Guilbaud E, Aaronson S, Abrams J, Adam D Cell Death Differ. 2023; 30(5):1097-1154.

PMID: 37100955 PMC: 10130819. DOI: 10.1038/s41418-023-01153-w.

TNFR2 as a Potential Biomarker for Early Detection and Progression of CKD.

Lousa I, Reis F, Viana S, Vieira P, Vala H, Belo L Biomolecules. 2023; 13(3).

PMID: 36979469 PMC: 10046457. DOI: 10.3390/biom13030534.

References

Boyce N, Holdsworth S . Evidence for direct renal injury as a consequence of glomerular complement activation. J Immunol. 1986; 136(7):2421-5. View

Pender M . Activation-induced apoptosis of autoreactive and alloreactive T lymphocytes in the target organ as a major mechanism of tolerance. Immunol Cell Biol. 1999; 77(3):216-23. DOI: 10.1046/j.1440-1711.1999.00818.x. View

Tomosugi N, Cashman S, Hay H, Pusey C, Evans D, Shaw A . Modulation of antibody-mediated glomerular injury in vivo by bacterial lipopolysaccharide, tumor necrosis factor, and IL-1. J Immunol. 1989; 142(9):3083-90. View

Baud L, Oudinet J, Bens M, Noe L, Peraldi M, Rondeau E . Production of tumor necrosis factor by rat mesangial cells in response to bacterial lipopolysaccharide. Kidney Int. 1989; 35(5):1111-8. DOI: 10.1038/ki.1989.98. View

Wuthrich R, Glimcher L, Yui M, Jevnikar A, Dumas S, Kelley V . MHC class II, antigen presentation and tumor necrosis factor in renal tubular epithelial cells. Kidney Int. 1990; 37(2):783-92. DOI: 10.1038/ki.1990.46. View

Schrijver G, Bogman M, Assmann K, de Waal R, Robben H, van Gasteren H . Anti-GBM nephritis in the mouse: role of granulocytes in the heterologous phase. Kidney Int. 1990; 38(1):86-95. DOI: 10.1038/ki.1990.171. View

Jevnikar A, Brennan D, Singer G, HENG J, Maslinski W, Wuthrich R . Stimulated kidney tubular epithelial cells express membrane associated and secreted TNF alpha. Kidney Int. 1991; 40(2):203-11. DOI: 10.1038/ki.1991.201. View

Vassalli P . The pathophysiology of tumor necrosis factors. Annu Rev Immunol. 1992; 10:411-52. DOI: 10.1146/annurev.iy.10.040192.002211. View

Karkar A, Koshino Y, Cashman S, Dash A, Bonnefoy J, Meager A . Passive immunization against tumour necrosis factor-alpha (TNF-alpha) and IL-1 beta protects from LPS enhancing glomerular injury in nephrotoxic nephritis in rats. Clin Exp Immunol. 1992; 90(2):312-8. PMC: 1554602. DOI: 10.1111/j.1365-2249.1992.tb07948.x. View

10.

Mombaerts P, Clarke A, Rudnicki M, Iacomini J, Itohara S, Lafaille J . Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages. Nature. 1992; 360(6401):225-31. DOI: 10.1038/360225a0. View

11.

Pfeffer K, Matsuyama T, Kundig T, Wakeham A, Kishihara K, Shahinian A . Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell. 1993; 73(3):457-67. DOI: 10.1016/0092-8674(93)90134-c. View

12.

Xie Y, Muller W . Molecular cloning and adhesive properties of murine platelet/endothelial cell adhesion molecule 1. Proc Natl Acad Sci U S A. 1993; 90(12):5569-73. PMC: 46762. DOI: 10.1073/pnas.90.12.5569. View

13.

Tartaglia L, Pennica D, Goeddel D . Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J Biol Chem. 1993; 268(25):18542-8. View

14.

Barbara J, Smith W, Gamble J, Van Ostade X, Vandenabeele P, Tavernier J . Dissociation of TNF-alpha cytotoxic and proinflammatory activities by p55 receptor- and p75 receptor-selective TNF-alpha mutants. EMBO J. 1994; 13(4):843-50. PMC: 394883. DOI: 10.1002/j.1460-2075.1994.tb06327.x. View

15.

de Jong J, Leenen P, Voerman J, van der Sluijs-Gelling A, Ploemacher R . A monoclonal antibody (ER-HR3) against murine macrophages. II. Biochemical and functional aspects of the ER-HR3 antigen. Cell Tissue Res. 1994; 275(3):577-85. DOI: 10.1007/BF00318826. View

16.

Radeke H, Emmendorffer A, Uciechowski P, von der Ohe J, Schwinzer B, Resch K . Activation of autoreactive T-lymphocytes by cultured syngeneic glomerular mesangial cells. Kidney Int. 1994; 45(3):763-74. DOI: 10.1038/ki.1994.101. View

17.

Lopez-Armada M, Gonzalez E, Egido J . Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-alpha and IL-6, and proliferation. J Immunol. 1994; 153(11):5247-55. View

18.

Erickson S, de Sauvage F, Kikly K, Gillett N, Sheehan K, Schreiber R . Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature. 1994; 372(6506):560-3. DOI: 10.1038/372560a0. View

19.

Neale T, Ruger B, MacAulay H, Dunbar P, Hasan Q, Bourke A . Tumor necrosis factor-alpha is expressed by glomerular visceral epithelial cells in human membranous nephropathy. Am J Pathol. 1995; 146(6):1444-54. PMC: 1870891. View

20.

Zhang H, Fleck M, Kern E, Liu D, Wang Y, Hsu H . Antigen presenting cells expressing Fas ligand down-modulate chronic inflammatory disease in Fas ligand-deficient mice. J Clin Invest. 2000; 105(6):813-21. PMC: 377462. DOI: 10.1172/JCI8236. View